Corticosteroid-induced osteoporosis

Am J Med Sci. 1997 Jan;313(1):41-9. doi: 10.1097/00000441-199701000-00007.

Abstract

The pathophysiology of corticosteroid-induced osteoporosis is outlined in this article. Treatment options, based upon our understanding of the pathophysiology, and a review of the available literature are offered.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / adverse effects*
  • Anabolic Agents / therapeutic use
  • Bone Development
  • Bone Resorption / prevention & control
  • Calcitonin / therapeutic use
  • Diphosphonates / therapeutic use
  • Estrogens / therapeutic use
  • Female
  • Humans
  • Male
  • Models, Biological
  • Osteoporosis / chemically induced*
  • Osteoporosis / physiopathology*
  • Osteoporosis / prevention & control
  • Sodium Fluoride / therapeutic use
  • Vitamin D / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Anabolic Agents
  • Diphosphonates
  • Estrogens
  • Vitamin D
  • Sodium Fluoride
  • Calcitonin